- Home
- ROIV vs PLNT Comparison
ROIV vs PLNT Comparison
Compare ROIV & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PLNT
- Stock Information
- Founded
- ROIV 2014
- PLNT 1992
- Country
- ROIV United Kingdom
- PLNT United States
- Employees
- ROIV N/A
- PLNT N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PLNT Hotels/Resorts
- Sector
- ROIV Health Care
- PLNT Consumer Discretionary
- Exchange
- ROIV Nasdaq
- PLNT Nasdaq
- Market Cap
- ROIV 7.8B
- PLNT 8.1B
- IPO Year
- ROIV N/A
- PLNT 2015
- Fundamental
- Price
- ROIV $11.28
- PLNT $106.15
- Analyst Decision
- ROIV Buy
- PLNT Strong Buy
- Analyst Count
- ROIV 4
- PLNT 16
- Target Price
- ROIV $17.50
- PLNT $105.69
- AVG Volume (30 Days)
- ROIV 6.6M
- PLNT 1.5M
- Earning Date
- ROIV 08-07-2025
- PLNT 08-05-2025
- Dividend Yield
- ROIV N/A
- PLNT N/A
- EPS Growth
- ROIV N/A
- PLNT 21.55
- EPS
- ROIV N/A
- PLNT 2.11
- Revenue
- ROIV $29,053,000.00
- PLNT $1,129,218,000.00
- Revenue This Year
- ROIV $2.64
- PLNT $20.70
- Revenue Next Year
- ROIV $378.09
- PLNT $10.29
- P/E Ratio
- ROIV N/A
- PLNT $51.30
- Revenue Growth
- ROIV N/A
- PLNT 10.26
- 52 Week Low
- ROIV $8.73
- PLNT $68.75
- 52 Week High
- ROIV $13.06
- PLNT $110.95
- Technical
- Relative Strength Index (RSI)
- ROIV 53.61
- PLNT 58.81
- Support Level
- ROIV $11.25
- PLNT $106.06
- Resistance Level
- ROIV $11.82
- PLNT $110.95
- Average True Range (ATR)
- ROIV 0.33
- PLNT 3.09
- MACD
- ROIV -0.00
- PLNT 0.12
- Stochastic Oscillator
- ROIV 52.97
- PLNT 73.82
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.